Insider Transaction of Mark P. Frissora

Mark P. Frissora, a director at BIOADAPTATIVES, INC., acquired 4,717 shares of Series D Convertible Preferred Stock on June 1, 2026. These shares were issued as compensation for board services and are convertible into common stock at a 100:1 ratio, subject to a 4.9% beneficial ownership limitation. The transaction code "J" indicates a disposition under a previously reported plan, and the acquisition price was $0.00. Post-transaction, Frissora holds 76,271 shares of Series D Convertible Preferred Stock. The preferred stock entitles the holder to 100 votes per share on matters of the Issuer, irrespective of the beneficial ownership limitation.